@gamaryanne there are new chemos in trials being offered now. I was offered one at UCLA with the criteria that one tested positive for the cld18.2 antibody, but I have elected not to go that route as the infusion time is 8 hrs and vomiting even during infusion seems to be a pretty certain side effect. I was also told by my UCLA oncologist to avoid removal of appendix even though my largest nodule is adjacent to it as it's risky and another one will just pop up; I was convinced of this. I stopped using the gem-abraxane combo following SBRT since I didn't fancy the oncoming neuropathy and my antigen was normal. I've asked to go back on it since it kept my meager 2 nodules at bay for over 1 year; now I must have a lot based on my antigen of over 13,000. I will use the ice booties and mittens this go around to try and avoid the neuropathy. You've provided such invaluable insight to all of us with your posts that please never see yourself as a burden. We are all fighting this together and I pray the phase 3 clinical trials for 6236 are successful and possibly end early if they prove they would be promising for our community versus waiting until 2026 for the results. I hope someone in the phase 3 6236 can post their progress, if allowed.